GlassScriptPhysician profile
Priyanka Shastri
NPI 1760986863
$1,826.83
in general payments reported to CMS, 2019-2025
18 companies · $235 in 2025
The $235 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.99 · 2022: $309 · 2023: $432 · 2024: $751 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,182 · Travel and Lodging: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,181.91 |
| Travel and Lodging | $236.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $363.25 | 2024 | Monarch, Monarch Platform |
| Regeneron Healthcare Solutions, INC. | $312.07 | 2022-2025 | Dupixent |
| Glaxosmithkline, LLC. | $225.62 | 2022-2025 | Nucala |
| Becton, Dickinson and Company | $131.53 | 2024 | Pristine |
| Penumbra, INC. | $125.00 | 2023 | Indigo System |
| Astrazeneca Pharmaceuticals LP | $124.74 | 2024 | Tezspire |
| Genentech USA, INC. | $99.99 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.68 | 2022 | |
| Intuitive Surgical, INC. | $83.51 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $69.52 | 2023 | Glassia |
| Grifols USA, LLC | $41.42 | 2025 | Prolastin-C Liquid |
| Verona Pharma, INC. | $39.14 | 2025 | Ohtuvayre |
| Ethicon INC. | $30.57 | 2024 | Monarch Platform |
| Pulmonx Corporation | $27.85 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Baxter Healthcare | $19.79 | 2025 | Hillrom - Vest System Model 105 Home Care |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $16.95 | 2024 | (Ak6) Vest Therapy |
| Esperion Therapeutics, INC. | $16.68 | 2025 | Nexletol |
| Bard Access Systems, INC. | $13.52 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priyanka Shastri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.